ES8101556A1 - Un procedimiento para la preparacion de derivados de imida- zol. - Google Patents

Un procedimiento para la preparacion de derivados de imida- zol.

Info

Publication number
ES8101556A1
ES8101556A1 ES486782A ES486782A ES8101556A1 ES 8101556 A1 ES8101556 A1 ES 8101556A1 ES 486782 A ES486782 A ES 486782A ES 486782 A ES486782 A ES 486782A ES 8101556 A1 ES8101556 A1 ES 8101556A1
Authority
ES
Spain
Prior art keywords
phenoxyalkyl
imidazoles
pharmaceutical compositions
synthetase enzyme
thromboxane synthetase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES486782A
Other languages
English (en)
Other versions
ES486782A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10501705&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8101556(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of ES486782A0 publication Critical patent/ES486782A0/es
Publication of ES8101556A1 publication Critical patent/ES8101556A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE DERIVADOS DE IMIDAZOL. CONSISTE EN HACER REACCIONAR IMIDAZOL CON UN HIDRURO DE METAL ALCALINO Y AÑADIR CON COMPUESTO DE FORMULA GENERAL (I). *FORMULA* SE OBTIENE UN COMPUESTO DE FORMULA GENERAL (II), SIENDO R: NO2, CN, SO2NH2; R ELEVADO A 1 ES H, ALQUILO C1-C4, ALCOXI C1-C4 O HALOGENO. INHIBICION DE LA ACCION DEL ENZIMA TROMBOXAMA-SINTETASA; INHIBICION DE LAS ENZIMAS PROSTACIDIN-SINTETASA O CICLO-OXIGENASA. TRATAMIENTO DE TROMBOSIS, ISQUIMIA, JAQUECA Y COMPLICACIONES VASCULARES DE DIABETES. T
ES486782A 1978-12-13 1979-12-11 Un procedimiento para la preparacion de derivados de imida- zol. Expired ES8101556A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7848367 1978-12-13

Publications (2)

Publication Number Publication Date
ES486782A0 ES486782A0 (es) 1980-12-16
ES8101556A1 true ES8101556A1 (es) 1980-12-16

Family

ID=10501705

Family Applications (1)

Application Number Title Priority Date Filing Date
ES486782A Expired ES8101556A1 (es) 1978-12-13 1979-12-11 Un procedimiento para la preparacion de derivados de imida- zol.

Country Status (34)

Country Link
US (2) US4602016A (es)
JP (1) JPS585197B2 (es)
KR (1) KR830001243B1 (es)
AR (1) AR227637A1 (es)
AT (1) AT373879B (es)
AU (1) AU517892B2 (es)
BE (1) BE880584A (es)
CA (1) CA1108137A (es)
CH (1) CH644597A5 (es)
CS (1) CS216517B2 (es)
DD (1) DD147943A5 (es)
DE (1) DE2950019A1 (es)
DK (1) DK471479A (es)
EG (1) EG14227A (es)
ES (1) ES8101556A1 (es)
FI (1) FI70888C (es)
FR (1) FR2444031A1 (es)
GB (1) GB2038821B (es)
GR (1) GR73003B (es)
HU (1) HU183016B (es)
IE (1) IE49318B1 (es)
IL (1) IL58917A (es)
IT (1) IT1194900B (es)
LU (1) LU81985A1 (es)
NL (1) NL177749C (es)
NO (1) NO153135C (es)
NZ (1) NZ192360A (es)
PH (1) PH15056A (es)
PL (1) PL134005B1 (es)
PT (1) PT70571A (es)
SE (1) SE444937B (es)
SU (1) SU878195A3 (es)
YU (1) YU301879A (es)
ZA (1) ZA796708B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
DE3148291A1 (de) * 1981-12-05 1983-06-09 Basf Ag, 6700 Ludwigshafen Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
JPS58113178A (ja) * 1981-12-28 1983-07-05 Yamanouchi Pharmaceut Co Ltd 「お」−(1−イミダゾリル)アルキルオキシ(またはチオ)ベンゼン誘導体
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
NL8301550A (nl) * 1983-05-03 1984-12-03 Gist Brocades Nv Imidazolethanol esters.
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
IT1212791B (it) * 1983-11-24 1989-11-30 Medea Res Srl Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono.
ES539074A0 (es) * 1984-12-10 1985-11-16 Ferrer Int Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
US4894385A (en) * 1985-01-16 1990-01-16 Sankyo Company Limited Imidazole derivatives as inhibitors of TXA2 synthesis
NO166644C (no) 1986-01-28 1991-08-21 Sankyo Co Analogifremgangsmaate til fremstilling av tianaftenderivater.
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
JPS63179840A (ja) * 1986-07-24 1988-07-23 Yamanouchi Pharmaceut Co Ltd 新規化学物質
EP0284892B1 (de) * 1987-04-03 1990-10-31 Cl Pharma Aktiengesellschaft Neue 2-Thienyloxyessigsäurederivate, ein Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
JPH01125372A (ja) * 1988-09-12 1989-05-17 Yamanouchi Pharmaceut Co Ltd イミダゾリルアルキルオキシベンゼン誘導体
DE4204686A1 (de) * 1992-02-17 1993-08-19 Gruenenthal Gmbh Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
AU2890899A (en) * 1998-03-13 1999-09-27 Pozen, Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
JP2005533830A (ja) * 2002-07-09 2005-11-10 ビー.エム.アール.エイ. コーポレイション ベスローテン フェンノートシャップ トロンボキサンa2受容体アンタゴニストおよびcox−2阻害剤の薬剤の組み合わせ
CA2534316A1 (en) * 2003-08-07 2005-02-24 B.M.R.A. Corporation B.V. Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxygenase-1
KR101275814B1 (ko) * 2006-06-23 2013-06-18 삼성에스디아이 주식회사 분산제 화합물 및 그의 제조방법
EP2543368A1 (en) 2007-12-11 2013-01-09 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN101811974B (zh) * 2010-04-15 2012-12-12 合肥医工医药有限公司 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途
CN101851209B (zh) * 2010-06-21 2012-09-19 合肥医工医药有限公司 咪唑乙基香草酸醚、其制备方法及其医药用途
EA026393B1 (ru) * 2012-05-22 2017-04-28 Дженентек, Инк. N-замещенные бензамиды и их применение в лечении боли
RU2015119640A (ru) 2012-10-26 2016-12-20 Мерк Шарп И Доум Корп. Соединения n-замещенного индазол-сульфонамида с избирательной активностью в потенциал-зависимых натриевых каналах
CN114736161B (zh) * 2022-06-13 2022-09-13 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途
WO2023240378A1 (zh) * 2022-06-13 2023-12-21 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534061A (en) * 1967-12-04 1970-10-13 Parke Davis & Co N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体

Also Published As

Publication number Publication date
JPS585197B2 (ja) 1983-01-29
AU517892B2 (en) 1981-09-03
SE7910204L (sv) 1980-06-14
ATA783379A (de) 1983-07-15
CS216517B2 (en) 1982-11-26
CH644597A5 (de) 1984-08-15
AU5372579A (en) 1980-06-19
IL58917A0 (en) 1980-03-31
NZ192360A (en) 1982-02-23
KR830001243B1 (ko) 1983-06-27
PL134005B1 (en) 1985-07-31
CA1108137A (en) 1981-09-01
ES486782A0 (es) 1980-12-16
DK471479A (da) 1980-06-14
DE2950019A1 (de) 1980-07-10
IT1194900B (it) 1988-09-28
LU81985A1 (fr) 1980-04-22
AT373879B (de) 1984-02-27
AR227637A1 (es) 1982-11-30
HU183016B (en) 1984-04-28
NO153135C (no) 1986-01-22
YU301879A (en) 1983-01-21
DD147943A5 (de) 1981-04-29
FR2444031A1 (fr) 1980-07-11
IT7941669A0 (it) 1979-12-11
SE444937B (sv) 1986-05-20
GB2038821A (en) 1980-07-30
IE792403L (en) 1980-06-13
FI793868A (fi) 1980-06-14
EG14227A (en) 1983-12-31
JPS5585572A (en) 1980-06-27
FI70888C (fi) 1986-10-27
NL7908899A (nl) 1980-06-17
NL177749B (nl) 1985-06-17
KR830001242A (ko) 1983-04-29
GR73003B (es) 1984-01-24
NO153135B (no) 1985-10-14
NL177749C (nl) 1985-11-18
PL220351A1 (es) 1980-12-01
ZA796708B (en) 1981-08-26
US4636500A (en) 1987-01-13
US4602016A (en) 1986-07-22
BE880584A (fr) 1980-06-12
IE49318B1 (en) 1985-09-18
PT70571A (en) 1980-01-01
FR2444031B1 (es) 1983-06-10
GB2038821B (en) 1982-12-08
PH15056A (en) 1982-06-03
IL58917A (en) 1984-03-30
SU878195A3 (ru) 1981-10-30
NO794069L (no) 1980-06-16
FI70888B (fi) 1986-07-18

Similar Documents

Publication Publication Date Title
ES8101556A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES8104278A1 (es) Un procedimiento para la preparacion de derivados del indol.
ES8101557A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
HUT67436A (en) Process to prepare novel hydroxamic acid and n-hydroxyurea derivatives and pharmaceutical compn.s contg. them
DK155143C (da) Antioestrogent laegemiddel til behandling af benigne og canceroese tilstande i brystet
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
ES8307744A1 (es) Un metodo para la preparacion de nuevos derivados de sales de metales alcalinos de acidos 2-pirrolidon-4-carboxilicos.
IL122401A0 (en) Anti-inflammatory compositions
MD1688G2 (ro) Benzotiofen, benzofuran şi indoltiazepinone, oxazepinone şi diazepinone, compoziţie farmaceutică, metodă de inhibare a aderării leucocitelor la celulele endoteliale pentru tratamentul proceselor inflamatorii şi metodă de tratament al mamiferelor infectate cu HIV infecţie .
ES486279A1 (es) Procedimiento para la obtencion de hidroxipropil-triazoles
FR1234879A (fr) Perfectionnements apportés aux produits pour l'extermination des animaux nuisibles et aux procédés pour préparer des anhydrides et des amides d'acides o, o-dialcoyldithiophosphoryl-gras utilisables comme matières actives dans ces produits
ES438931A1 (es) Procedimiento para la preparacion de nuevos derivados de amino-3 hidroxi-2 fenoxi-1 propano.
GB1335783A (en) Anti-seborrhoeic compositions
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DK0413793T3 (da) Koncentrerede vandige emulsioner, en fremgangsmåde til deres fremstilling og deres anvendelse på pesticidområdet
ES451880A1 (es) Procedimiento de preparacion de una nueva composicion den- tifrica.
ATE110714T1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
ID26240A (id) Formulasi obat setengah padat yang mengandung dekstoprofen trometamol
ES447307A1 (es) Procedimiento para la preparacion de una 1-(alfa-sustituida--aminoacil)-3-desoxirribostamicina.
IT1209419B (it) Composti ad attivita' mucolitica non assimilabili, processo per laloro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
ES269442A1 (es) Procedimiento de preparaciën de orotato de lisina
FR2455610A1 (fr) Nouveaux steroides inhibiteurs de la 5a-reductase, utiles notamment pour le traitement de l'acne et leur procede de preparation
FR2113947A1 (en) Oral raubasine compositions - also contg polyethylene glycol to improve resorption
ES419165A1 (es) Un metodo de preparar una formulacion farmaceutica que in- cluye un 3-amino-prop-1-eno sustituido.